Compounds, compositions and methods for protecting brain health in neurodegenerative disorders

Details for Australian Patent Application No. 2010275476 (hide)

Owner Amazentis SA

Inventors Rinsch, Christopher; Dupraz, Philippe Victor Leon

Agent Shelston IP

Pub. Number AU-A-2010275476

PCT Pub. Number WO2011/011721

Priority 61/228,374 24.07.09 US

Filing date 23 July 2010

Wipo publication date 27 January 2011

International Classifications

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 407/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

Event Publications

15 March 2012 PCT application entered the National Phase

  PCT publication WO2011/011721 Priority application(s): WO2011/011721

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010275477-Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mGluR4 potentiators

2010275475-Bone plate screw-blocking systems and methods